Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Income (2016 - 2025)

STRATA Skin Sciences' Operating Income history spans 13 years, with the latest figure at -$1.0 million for Q3 2025.

  • For Q3 2025, Operating Income rose 35.02% year-over-year to -$1.0 million; the TTM value through Sep 2025 reached -$3.3 million, up 60.61%, while the annual FY2024 figure was -$9.3 million, 7.57% down from the prior year.
  • Operating Income for Q3 2025 was -$1.0 million at STRATA Skin Sciences, up from -$2.3 million in the prior quarter.
  • Across five years, Operating Income topped out at $1.7 million in Q4 2024 and bottomed at -$3.4 million in Q4 2023.
  • The 5-year median for Operating Income is -$1.6 million (2024), against an average of -$1.4 million.
  • The largest annual shift saw Operating Income plummeted 2667.91% in 2023 before it surged 150.71% in 2024.
  • A 5-year view of Operating Income shows it stood at -$622000.0 in 2021, then skyrocketed by 121.54% to $134000.0 in 2022, then tumbled by 2667.91% to -$3.4 million in 2023, then soared by 150.71% to $1.7 million in 2024, then tumbled by 159.77% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Operating Income are -$1.0 million (Q3 2025), -$2.3 million (Q2 2025), and -$1.7 million (Q1 2025).